Michael Schmidt
Stock Analyst at Guggenheim
(4.37)
# 344
Out of 4,960 analysts
116
Total ratings
60.87%
Success rate
13.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRSN Mersana Therapeutics | Maintains: Buy | $125 → $30 | $7.75 | +287.10% | 4 | Aug 14, 2025 | |
| ADCT ADC Therapeutics | Reiterates: Buy | $10 | $3.18 | +214.47% | 6 | Aug 13, 2025 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $18 | $9.74 | +84.80% | 6 | Aug 13, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $10 → $12 | $3.02 | +297.35% | 5 | Aug 12, 2025 | |
| ONC BeOne Medicines | Maintains: Buy | $350 → $365 | $313.67 | +16.36% | 4 | Aug 7, 2025 | |
| ARVN Arvinas | Maintains: Buy | $16 → $15 | $7.32 | +104.92% | 6 | Aug 7, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $10 | $6.90 | +44.93% | 1 | Aug 6, 2025 | |
| COGT Cogent Biosciences | Reiterates: Buy | $17 | $12.12 | +40.26% | 1 | Jul 8, 2025 | |
| RVMD Revolution Medicines | Reiterates: Buy | $80 | $37.01 | +116.16% | 4 | Jun 25, 2025 | |
| AVBP ArriVent BioPharma | Reiterates: Buy | $45 | $20.11 | +123.77% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $15 | $19.44 | -22.84% | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $52 | $44.10 | +17.91% | 1 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $3.69 | +171.00% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $16.24 | +97.04% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $10.09 | -20.75% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $67.49 | +61.51% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $1.75 | $0.06 | +2,975.57% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $9.08 | +54.19% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $25 | $10.30 | +142.72% | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $92 | $85.04 | +8.18% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $35.56 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $38.63 | +8.72% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.54 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.11 | +543.09% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.99 | +302.01% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.93 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.15 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.89 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.19 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $8.41 | +304.28% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $0.73 | +2,650.65% | 3 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $24.65 | - | 2 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $1.60 | +1,462.50% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $4.82 | +522.41% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $3.50 | +642.22% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.85 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $38.80 | +106.19% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $9.07 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $3.59 | +53.20% | 2 | Nov 7, 2017 |
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $125 → $30
Current: $7.75
Upside: +287.10%
ADC Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $3.18
Upside: +214.47%
ORIC Pharmaceuticals
Aug 13, 2025
Reiterates: Buy
Price Target: $18
Current: $9.74
Upside: +84.80%
Compass Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $3.02
Upside: +297.35%
BeOne Medicines
Aug 7, 2025
Maintains: Buy
Price Target: $350 → $365
Current: $313.67
Upside: +16.36%
Arvinas
Aug 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $7.32
Upside: +104.92%
Tango Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $10
Current: $6.90
Upside: +44.93%
Cogent Biosciences
Jul 8, 2025
Reiterates: Buy
Price Target: $17
Current: $12.12
Upside: +40.26%
Revolution Medicines
Jun 25, 2025
Reiterates: Buy
Price Target: $80
Current: $37.01
Upside: +116.16%
ArriVent BioPharma
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $20.11
Upside: +123.77%
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $19.44
Upside: -22.84%
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $44.10
Upside: +17.91%
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $3.69
Upside: +171.00%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $16.24
Upside: +97.04%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $10.09
Upside: -20.75%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $67.49
Upside: +61.51%
Mar 26, 2025
Maintains: Buy
Price Target: $3 → $1.75
Current: $0.06
Upside: +2,975.57%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $9.08
Upside: +54.19%
Mar 20, 2025
Maintains: Buy
Price Target: $35 → $25
Current: $10.30
Upside: +142.72%
Mar 18, 2025
Downgrades: Neutral
Price Target: $92
Current: $85.04
Upside: +8.18%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $35.56
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $38.63
Upside: +8.72%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.54
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $3.11
Upside: +543.09%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.99
Upside: +302.01%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $32.93
Upside: -
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.15
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.89
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $8.41
Upside: +304.28%
Jun 27, 2023
Downgrades: Neutral
Price Target: $20
Current: $0.73
Upside: +2,650.65%
Jan 3, 2022
Downgrades: Neutral
Price Target: n/a
Current: $24.65
Upside: -
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $1.60
Upside: +1,462.50%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $4.82
Upside: +522.41%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $3.50
Upside: +642.22%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.85
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $38.80
Upside: +106.19%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $9.07
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $3.59
Upside: +53.20%